Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy
- PMID: 29367327
- DOI: 10.1136/ebmed-2017-110849
Trial supports targeted radiotherapy for early breast cancer but protocol still requires 3 weeks of daily therapy
Keywords: Breast cancer; IORT; TARGIT; intraoperative radiotherapy; lumpectom; partial breast irradiation (PBI); patient benefit; targeted radiotherapy.
Conflict of interest statement
Competing interests: Carl Zeiss has sponsored some travel to some conferences and has paid some honoraria.
Comment on
-
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2. Lancet. 2017. PMID: 28779963 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
